Examining individual serotonin and norepinephrine reuptake inhibitors and fall-related hospitalizations in older adults

Lakedra E. White; Chelsea A. Keedy; Jianing Xu; Kristen N. Pierce; David W. Hall; Jinae Lee; Ashlee C. Greene; Robin J. Jacobs

doi:10.9740/mhc.2026.02.020

February 1, 2026Mental Health ClinicianOpen Access

Examining individual serotonin and norepinephrine reuptake inhibitors and fall-related hospitalizations in older adults

View Full Paper

Ask AI

Bookmark

Share

Key Points

Venlafaxine has a lower fall risk compared to duloxetine, while confirming the need for further studies.
The study indicates a need to explore clinical significance regarding fall-related events in older populations.
Analysis showed key differences in hospitalizations linked to different serotonin and norepinephrine reuptake inhibitors.
Further investigation is essential to clarify the financial impacts of falls associated with SNRI use in older adults.

Implication

Observational analysis examines fall-related hospitalizations in older adults, suggesting safer SNRI use may be possible.

Abstract

Venlafaxine appears to have a lower fall risk than duloxetine. Further studies are needed to determine clinical significance and assess fall-related costs to support safer SNRI use in older adults.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

White et al. (2026) studied this question.

synapsesocial.com/papers/69a7608bc6e9836116a2d645 https://doi.org/10.9740/mhc.2026.02.020

View Full Paper

Ask AI

Bookmark

Share

Examining individual serotonin and norepinephrine reuptake inhibitors and fall-related hospitalizations in older adults

Key Points

Implication

Abstract

Discussion

Cite This Study

Examining individual serotonin and norepinephrine reuptake inhibitors and fall-related hospitalizations in older adults

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

More from Mental Health Clinician

Keep reading

More from Mental Health Clinician